A Clinical Phase I Study on GIC-1001 in Healthy Volunteers

NCT01738425 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Colonic Diseases

Interventions

DRUG: GIC-1001; 125 mg oral tablets
DRUG: GIC-1001 matching placebo

Sponsor

gicare Pharma Inc.